Home/Pipeline/Infectious Disease Diagnostics Program

Infectious Disease Diagnostics Program

Infectious Diseases

DiscoveryActive

Key Facts

Indication

Infectious Diseases

Phase

Discovery

Status

Active

Company

Aptus Biosciences

About Aptus Biosciences

Aptus Biosciences is a private, pre-revenue diagnostics company focused on reinventing aptamer technology for clinical applications. The company is developing a platform of chemically modified DNA aptamers designed as high-specificity, high-affinity reagents for detecting disease biomarkers. Its initial pipeline targets major therapeutic areas including neurology, oncology, cardiology, and infectious diseases, with the goal of enabling earlier and more accurate diagnosis. As an early-stage venture, Aptus is likely seeking partnerships and investment to advance its programs from platform development into validated diagnostic assays.

View full company profile

Therapeutic Areas

Neurology Oncology Cardiology Infectious Diseases

Other Infectious Diseases Drugs

Drug	Company	Phase	Status
inPROBE Platform	SDS Optic	Early R&D	Active
Potential Human POC Diagnostics	MatMaCorp	Research	Active
Nanoparticle Vaccines	Opko Health	Research	Active
Platform Vaccine Applications	Chimeron Bio	Discovery	Research
FMN riboswitch modulator	Acellera	Pre-clinical	Hit Identification
NP-G2-044	Novita Pharmaceuticals	Pre-Clinical	Exploratory
Ramoplanin™	Nanopharmaceutics	Clinical	Active
NanoDOX™	Nanopharmaceutics	Clinical	Active
Infectious Diseases	Menarini	Clinical	Active
Undisclosed Infectious Disease Program(s)	ATB therapeutics	Pre-clinical	Active
Vaccines for Infectious Diseases (undisclosed)	Takis	Pre-clinical	Active
Undisclosed Multispecific Therapeutics	ModeX Therapeutics	Pre-clinical	Active